Chairman and Managing Director-Dr.Agarwal’s group of eye hospitals and Eye Research Centre, 222, TTK Road, Alwarpet, Chennai 600018, Tamilnadu, India
Past President- International Society of Refractive Surgery (ISRS)
Secretary General- Indian Intraocular implant and Refractive Society (IIRSI)
Amar Agarwal is the pioneer of Phakonit, which is Phako with a Needle Incision Technology. This technique became popularized as Bimanual phaco, Microincision cataract surgery (MICS) or Microphaco. He was the first to remove cataracts through a 0.7 mm tip with the technique called Microphakonit. He has also discovered No anaesthesia cataract surgery and FAVIT, a new technique to remove dropped nuclei. The air pump, which was a simple idea of using an aquarium fish pump to increase the fluid into the eye in bimanual phaco and co-axial phaco has helped prevent surge. This built the basis of various techniques of forced infusion for small incision cataract surgery. He has also discovered a new refractive error called Aberropia. He has also been the first to do a combined surgery of microphakonit (700 micron cataract surgery) with a 25 gauge vitrectomy in the same patient thus having the smallest incisions possible for cataract and vitrectomy. He is also the first surgeon to implant a new mirror telescopic IOL (LMI) for patients suffering from age-related macular degeneration. He has also been the first in the world to implant a Glued IOL. He also has brought out the technique of IOL Scaffold in which a three-piece IOL is injected into an eye between the iris and the nucleus to prevent the nucleus from falling down in posterior capsular ruptures. Hypersonic vitrectomy for cases of PC rupture was first done by him and he was the principal investigator for the first hypersonic vitrectomy cases done in the world.
Pre Descemet’s Endothelial Keratoplasty or PDEK was started by Prof Agarwal. Dr Agarwal has designed a new instrument called the Trocar anterior chamber maintainer in complicated cases, which helps give infusion through the anterior chamber and works like a trocar cannula. He has also started a new technique of iris suturing called Single pass Four Throw (SFT) pupilloplasty. Subsequenly he started Pinhole pupilloplasty to treat patients with high astigmatism and higher order aberrations.
Dr. Agarwal has performed more than 200 live surgeries at various conferences. His videos have won many awards at the film festivals of ASCRS, AAO and ESCRS. He has more than 250 peer review articles in top journals and has also written more than 80 books in Ophthalmology which have been published in English, Spanish, portugese and chinese. He is the Chairman and managing director of Dr.Agarwals group of eye hospitals with 221 eye hospitals in 11 countries.
With over 13 years of experience in the global eyecare and eyewear industry, Andrea Fornari has held executive roles spanning corporate offices in Milan, Dubai, and South Africa. Currently, he leads the GCC and Export markets in EssilorLuxottica, focusing on frames, lenses, instruments, apparel, and wearable solutions. His strategic vision and leadership drive growth and cross-regional business development, making significant contributions to the industry. Andrea is known for his ability to foster innovation and build strong partnerships across diverse markets, positioning him as a key player in shaping the future of eyewear and eyecare.
Andrew G. Lee is the Herb and Jean Lyman Centennial Chair in Ophthalmology and is the Founding Chairman of the Blanton Eye Institute, Department of Ophthalmology at Houston Methodist Hospital in Houston, Texas. He is Professor of Ophthalmology, Neurology, and Neurosurgery at Weill Cornell Medicine and an adjunct professor of Ophthalmology at Baylor College of Medicine; Texas A and M College of Medicine; University of Iowa and the University of Buffalo; and Clinical Professor at the University of Texas Medical Branch (UTMB) in Galveston, Texas and the UT MD Anderson Cancer Center.
He is a graduate of the University of Virginia (UVA) undergraduate and UVA School of Medicine. He was an ophthalmology resident and chief resident at Baylor College of Medicine and a clinical neuro-ophthalmology fellow and Fight for Sight postdoctoral research fellow at the Wilmer Eye Institute, the Johns Hopkins Hospital.
Dr. Lee has served in numerous leadership roles at the American Academy of Ophthalmology (AAO) and has received the AAO Achievement Award, Senior Achievement Award, Secretariat Award (three times), and Lifetime Achievement Award. He is a past President, a past Chairman of the Board, and Senior VP for Advocacy of the North American Neuro-ophthalmology Society.
Dr. Lee has received the teaching award 15 times at 7 different academic institutions including the Osler Excellence in Teaching Award, the Baylor College of Medicine Dan B. Jones Teaching Award, University of Iowa Charles Phelps Award, the Texas A and M Mid Career Education award, the HMH Presidential Excellence in Education, and the Houston Methodist Hospital Sherilynn Gordon Memorial Leadership Award.
Dr. Lee has been the invited speaker at over 400 national and international medical meetings; has written over 600 peer-reviewed publications and 14 full textbooks; and has given 15 named lectures. His h-index is 68 and his i-10 is 367 with over 18,000 citations. He has been named one of top 30 ophthalmologists in the United States by Newsweek magazine and is the only neuro-ophthalmologist on the list.
He lives in Houston, Texas with his wife, Hilary; his two daughters (Rachael and Virginia), and his two cats (Lola and Miss Kitty).
Dr. André Maia is a Brazilian ophthalmologist specializing in clinical and surgical retina. He earned his M.D. and completed his ophthalmology residency at the Federal University of São Paulo (UNIFESP), where he also obtained a Ph.D. in Medicine (Ophthalmology) in 2003, with a thesis on retinal vein catheterization for the treatment of venous occlusions. He pursued a Retina fellowship at McGill University in Canada, under the supervision of Drs. David Chow and Michael Kapusta. Dr. Maia is currently the medical director of Retina Clinic in São Paulo and leads a specialized team focused on the diagnosis and management of complex retinal diseases. He has been an active contributor to scientific research and education in ophthalmology and has presented at multiple national and international congresses. He is fluent in Portuguese and English, and has working knowledge of Spanish and French. His expertise bridges advanced surgical techniques and evidence-based clinical practice.
Dr. Ashvin Agarwal is the Chief Clinical Officer at Dr. Agarwal’s Eye Hospital, a premier eye care group spanning over 170+ locations globally. In this capacity, he spearheads initiatives vital to maintaining the organization’s clinical excellence and fostering its expansion.
Dr. Agarwal has been honored with the prestigious Golden Apple Award from ASCRS and esteemed Secretariat award from American Academy of Ophthalmology accolade, underscoring his profound contributions to the field. Additionally, his prolific scholarly output includes over 25 publications and the authorship of 10 seminal books, reflecting his dedication to advancing knowledge in ophthalmology.
Dr Barbara Parolini was born in Verona, Italy, on April 17th, 1968.
She is an ophthalmic surgeon who exercises her practice, mainly in Italy, since 1997. She graduated in Italy from Medical School with laude in 1993 and obtained the diploma in Ophthalmology in 1997.
She has undertaken a postdoctoral fellowship at UCSF (San Francisco, USA) and at UMDNJ (Newark, USA), on retinal pigment epithelium transplantation in 1994-1995 and 1997-1998.
She has been Director of Clinical Studies for FDA for the Medjet Company, in Edison USA, in 1997-1998.
She works as consultant in foreign countries.
Her expertise are:
She has operated about 15000 cases
She has published
She is teacher at:
She has performed live surgery in Italy and abroad. Of note, at:
She serves as Reviewer of the following peer reviewed-journals:
Approved at the exam of the Italian Ministry as University Associate Professor
Organiser of 3 international meetings, Retinitaly in 2015, 2016, 2017
Since 2016, VicePresident of the European VitreoRetina Society
Since 2020 Board member or Retina World Congress and leading the RWC- Global Research Group
She obtained a patent of a model of macular buckle and a kit for episcleral surgery.
Member of the following societies: GIVRE, SOI, AIMO, AAO, ASRS, EVRS
16 June 2023 Awarded with the DOC Retina Science Award
Professor Bruce Allan qualified in medicine from Cambridge in 1985, and was appointed as a Consultant Surgeon at Moorfields in 1998 after advanced specialist training in the UK, South Africa, and Australia. He was Training Director for the Corneal Service at Moorfields for over 10 years, and Service Director for Refractive Surgery from 2012 to 2019. He is currently chairing the Royal College of Ophthalmologists Refractive Surgery Standards Working Group and the European Society of Cataract and Refractive Surgeons (ESCRS) Digital Health Special Interest Group. He is an ESCRS Council and EU Cornea board member.
He and his wife, Consultant Psychiatrist Dr Maria Teresa Casasus Borrell, live in North London with regular visits from their 3 daughters, Saskia, Sofia and Silvia. Outside work, He is a keen football fan and sailor.
Professional activities include:
Current research interests include:
Burkhard Dick was born in a small town by the name of Brake in Northern Germany. After graduating from the local high school, he served for two years as a medical officer with Germany’s NATO forces. He attended medical school at the University of Giessen, a city with a strong American presence during the Cold War, where he graduated in 1990, a year that saw German unification and changed Giessen’s location where he began his residency in ophthalmology from bordertown at the edge of the Iron Curtain to suddenly being in the country’s geographical centre.
Dick became head physician at the University Eye Hospital in 1995 before he moved to the Eye Hospital of the University of Mainz which bears the name of that city’s greatest son, Johannes Gutenberg. Here he specialized in refractive and cataract surgery and became head of the hospital’s Refractive Surgical Eye CareCenter in 1997. Shortly after becoming a clinical professor in Mainz, the University of Bochumoffered offered Burkhard Dick the position of head and director of its eye clinic and eye research centre which he accepted in 2006. Since then, the Bochum University Eye Clinic has become an internationally renowned institution with a constant output of highly ranked research papers and clinical studies, most of them published in the Journal of Cataract and Refractive Surgery and the Journal of Refractive Surgery.
Burkhard Dick became one of the first ophthalmic surgeons in Europe to use a femtosecond laser in cataract surgery; to date almost 12,000 eyes have been operated with that technology in Bochum.
For his pioneering work, he has been awarded a number of honours like the Choyce Medal of the British Ophthalmological Society, the Gold Medal Award of the Australian Society for Cataract and Refractive Surgery, the Waring Medal of the Journal of Refractive Surgery and, most recently, the Visionary Award of the American-European Congress of Ophthalmic Surgery (AECOS).
He currently serves as the Treasurer of the German Society of Cataract, Refractive and Interventional Surgery (DGII) after being President of the DGII for four years (2016-2020). He is a regular lecturer at international meetings like the AAO, DOG, DOC, DGII, ESCRS, APAO and ASCRS and has instructed fellows in the University Eye Hospital Bochum from 44 different countries in state-of-the-art cataract, refractive, glaucoma and vitreoretinal surgery.
Eye surgeon specializing inVitreoretinal Surgery, with over 35 years of experience. He currently works at the Miranza Group Institute of Ocular Microsurgery (IMO) in Barcelona and at Miranza Andorra. He is a founding member of the IMO and has worked at institutions such as the General Hospital Valle Hebrón and the General Hospital of Catalonia. He is an expert in pathologies such as high myopia, retinal detachment, severe ocular trauma, and diabetic retinopathy. He introduced innovative techniques such as Macular Translocation and Macular Buckling to Spain. He is an associate professor on the Master’s Degree in Retina and Vitreous at the Autonomous University of Barcelona and a part-time lecturer on retina modules at the European School for Advanced Studies in Ophthalmology (ESASO).
Dr. McCabe serves as Chief Medical Officer at Eye Health America™. She is one of the foremost eye surgeons today, specializing in bladeless laser cataract surgery and LASIK at The Eye Associates in Sarasota, Florida. Dr. McCabe has performed over 45,000 cataract surgeries and more than 17,000 LASIK procedures. She has a keen interest in advancing the field of ophthalmology and has participated in numerous clinical trials, including innovations in intraocular lenses, perioperative medications, medications and devices to treat glaucoma, dry eye treatments and presbyopia correction.
Dr. McCabe continues to receive many prestigious and esteemed awards for her work in Ophthalmology, including being named a Castle Connolly Top Doctor – 2015, 2016, 2017, 2018, 2019 and 2020 for Ophthalmology. Castle Connolly also selected her for the first-ever Exceptional Women In Medicine Award for 2017, 2018, 2019 and in 2020. She was named to the OSN Premier Surgeon 300 List, and the Premier Surgeon 250 List of Leading Innovators in Premium IOL Cataract Surgery. She was also chosen a LASERVISION Top 100 LASIK Surgeon, elected President of CEDARS/ASPEN-2017, has received the American Academy Achievement Award, is the Vice President and incoming President of the Outpatient Ophthalmic Surgery Society, and serves on numerous editorial and subspecialty boards and committees. She is passionate about giving back to her local community, profession and globally and participates in charitable giving and volunteer efforts both at home and abroad. She is a board member of several charitable foundations in ophthalmology, including One World Global Health/Vision Quest, OOSS Gives, and others.
Dr. McCabe received her medical degree from the Medical College of Wisconsin and received her residency training at the prestigious Bascom Palmer Eye Institute at the University of Miami’s School of Medicine. She continues to share her expertise by publishing articles and book chapters as well as lecturing at national and international ophthalmological seminars.
Daniele Tognetto is Full Professor of Ophthalmology and Director of the Eye Clinic at the University of Trieste, where he has performed over 20,000 surgical procedures on cataract, retina, cornea, and glaucoma; graduated in Medicine and Surgery with honors in 1987 and specialized in Ophthalmology with honors in 1991, he has progressed from researcher to full professor, leading the residency program and training new generations of surgeons; his research focuses on vitreoretinal and cataract surgery, intraocular lenses, biomaterials, and artificial intelligence applications in ophthalmology, resulting in more than 160 peer-reviewed publications and several scientific book chapters; he has been an invited speaker at numerous international congresses and has performed over 40 live surgeries at major scientific events; past President of the Italian Society of Cataract and Refractive Surgery (AICCER) and formerly President of the Italian Society of Vitreoretinal Surgeons (GIVRE) and the Triveneta Ophthalmology Society (SOT), he is also an active member of leading international ophthalmic societies; throughout his career he has received prestigious awards, including two Best Paper Awards from the American Society of Cataract and Refractive Surgery (ASCRS) and several prizes from the Italian Society of Ophthalmology (SOI).
Heads the Cataract and Glaucoma departments at Megur Eye Care Centre, Bidar Karnataka India.
Specialises in Complex Cataract Surgeries. He is committed to teaching surgery through his personal Youtube Channel.
He has more than 200 presentations at various national and international meetings. He is a reviewer for the Indian Journal Of Ophthalmology. He has won many national & international awards for scientific Papers and Videos.
Born in Paris, in 1957
Medical studies in Paris. Residency (Ophthalmology) in Toulouse. Fellowship (PO&S) in Toulouse and Nantes (Pr Quere). Private practice in Toulouse and consultant surgeon in Toulouse Universitary Hospital from 1992, exclusively surgical pediatric ophthalmology and strabismology. Teacher in Toulouse Orthoptic school, and French Universitary Diploma of Strabology and Pediatric ophthalmology.
Active member of French Society of Ophthalmology. Co-author of both Pediatric ophthalmology (2017) and Strabismology (2013) annual books of the society.
Former vice president of French association of PO&S. (AFSOP) and of European Strabismological Association.
Member of AAPOS, ISA, and WSPOS. Member of IPOSC for AFSOP representation. Local organiser of the last ESA/ISA meeting in my hometown, Toulouse in 2024.
Field of works and publications since 1990: Deprivation amblyopia, Infantile cataracts, Infantile Strabismus, strabismus surgery in general, and more precisely in Infantile strabismus, Botulinum Toxin, in high Myopia, Oblique muscle surgery. Recent works on global scoring of IXT and surgery of exotropia with combined recess and resect on same muscle.
… and still time for hobbies that I share with my 3 boys, 5 grand-children and my friends: music, mountain climbing, sailing, hiking.
Renowned ophthalmologist and academic leader with over three decades of experience in ocular surface diseases, dry eye, and inflammation. Currently serving as Chair of Ophthalmology at Universidad Complutense de Madrid and Head of the Ocular Surface and Inflammation Unit at Hospital Clínico San Carlos. Internationally recognized for contributions to research, education, and clinical practice in ophthalmology.
Fabio Patelli, M.D. is the director of vitreoretinal service department of Ophthalmology at the ASST Santi Paolo e Carlo Hospital, University of Milan. He graduated magna cum laude at the University of Milan and specialized in Ophthalmology magna cum laude at the San Raffaele Hospital, University of Milan.
He did a brief fellowship in Boston at the Massachusetts Eye and Ear Infirmary Hospital with Prof Donald J D’Amico and in New York at the Columbia University with Prof. Stanley Chang.
His main field of interest since he was a resident is vitreoretinal surgery. He is author of many papers and Editor of THREE books about vitreoretinal surgery (Springer ed.).
Complementing his research endeavors, Dr. Patelli serves on numerous scientific advisory boards and addresses his research interests as an invited speaker at national and international conferences.
He is reviewer of several journal as “Retina”, “European Journal of Ophthalmology”, “Graefe’s Archive for clinical and experimental Ophthalmology” and he is part of the editorial board of “Journal of vitreoretinal diseases”.
He is one of the few surgeons worldwide who implanted the Argus II artificial retina in blind patients.
He is member of many ophthalmological societies such as SILO (Italian Society Laser in Ophthalmology), SOI (Italian Society of Ophthalmology), S.I.E.T.O. (Italian Society of Ocular Trauma), G.I.V.R.E. (Italian Group of vitreoretinal surgery), ASRS (American Society of Retina Specialists), EVRS (European Vitreo-Retinal Society), PAAO (Pan American Association of Ophthalmology), AAO (American Academy of Ophthalmology), Euretina (European retina society) Retina society.
Professor Farhad Hafezi is a refractive surgeon and ocular cell biologist. Combing patient care, research & development, and teaching, Hafezi is considered a pioneer and key opinion leader of corneal cross-linking (CXL).
Hafezi is one of the most cited ophthalmologists of his generation. (> 260 peer-reviewed publications, h index of 63, > 17.000 citations, cumulative impact factor 1.045 points.
Born and raised in Rio de Janeiro, Brazil. After completing medical school and residency in Rio de Janeiro, Flavio went to McGill University, Montreal, Canada where he completed his Surgical Retina fellowship under mentorship of Drs Michael Kapusta and David Chow. Still at McGill, he also completed Ocular Oncology and Ophthalmic Pathology fellowships. Then finished his PhD degree in Science at University of São Paulo, Brazil.
He became an Associate Professor of the Department of Ophthalmology at Pontifícia Universidade Católica (PUC) – Rio de Janeiro and although he moved to Canada 15 years ago, still gives his annual Retina Course at PUC-Rio.
In Montreal, he serves as Full Professor from the Department of Ophthalmology, University of Montreal (UdeM), where he leads the clinical/surgical side of the translational research team at the Centre Universitaire d’Ophtalmologie, Maisonneuve-Rosemont Hospital (CUO-HMR), Montreal, Quebec, Canada. His main focus is on surgical management of complex vitreoretinal diseases, academic teaching, and surgical translational research up to clinical trials.
As a vitreoretinal surgeon, he has been developing and improving complex vitreoretinal surgical techniques to manage vitreoretinal diseases and now leads the CLOSE Study Group for large macular holes studies.
On the academic side, he was in charge of the Vitreoretinal Fellowship Program from the Retina Service, Department of Ophthalmology, UdeM for 5 years (2013-2018). He is now creating the Flavio Rezende Surgical Teaching Foundation (FIER) in memory of his recently departed father (a former well-known anterior segment surgeon in Brazil). He’s constantly involved in training fellows and residents at UdeM.
As a surgical translational researcher, he has developed surgical techniques to obtain vitreous biopsies in an ambulatory setting, providing instrumental material for the Neuro-Vascular Biology Research Unit at CUO-HMR. Two molecules out this lab are in ongoing clinical trials in the US and Canada.
Flavio was also involved for 5 years with the implantation of ARGUS 2 Retinal Chip implant and helped developing an innovative surgical technique for a new generation retinal chip.
And finally, in the past 4 years he has served as the Clinical Director at CUO-HMR and, as such, he has been committed to bringing further innovation to benefit his patients and the Quebec community. We have become now one of the first centers in Canada for subretinal gene therapy for previously untreatable retinal conditions.
Dr. Gerardo López Oseguera is an ophthalmologist and biomedical engineer specialized in anterior segment and retina surgery. He completed fellowships at the Instituto de Microcirugía Ocular (IMO) in Barcelona and holds an MBA in Health Innovation. Founder of Eyedictive, he focuses on developing novel surgical and diagnostic technologies, including the Oseguera Ring—a scleral fixation device for intraocular lens stabilization. His work bridges clinical practice and medical device innovation, with ongoing collaborations in preclinical validation and global ophthalmic research initiatives.
Giampaolo Gini is a general ophthalmic surgeon with a specific interest in retina.
He has been performing vitreo retinal surgery since 1990.
He is currently a substantive Consultant at University Hospitals Sussex NHS Trust with a specific role as vitreo-retinal surgeon while still maintaining an active private practice both in Italy and in the UK.
In the past he has covered several Consultant posts both for the Italian (SSN) as well as the British (NHS) National Health systems.
He has a considerable surgical experience with roughly 25.000 procedures on the anterior segment and 18.000 on the posterior segment of the eye. Because of this he has always been employed to deal with the more challenging cases on theatre lists.
Through the years he has developed a special interest in diabetes and ocular trauma surgery.
He is also known internationally as being one of the first surgeons to challenge the results of the Early Vitrectomy Study for the treatment of endophthalmitis. The paper published in 2006 (Vitrectomy for Endophthalmitis; Kuhn and Gini in “Ophthalmology”) helped pave the way for others to follow with their own experiences.
Dr Gini is an internationally recognised clinician, surgeon and educator.
He has received numerous international awards, among which the coveted Italian Ophthalmological Society Award (twice), the Royal College of Ophthalmologists’ Treacher-Collins Award and the American Society of Retina Specialists Reis-Buckler Award (twice).
He has frequently been involved in “live surgery” meetings both at home and abroad.
As a lecturer he has accumulated over 900 hours of activity in meetings in every part of the World.
He is an Associate Professor of Ophthalmology at Maimonides University Medical School (Buenos Aires, Argentina) and Visiting Professor of Ophthalmology at Yale University (New Haven, Connecticut, USA).
He has served as Board Member and Secretary of the European Vitreo Retinal Society of which he is currently President.
He has been named Liaison Officer to Europe for the American Society of Retina Specialists (ASRS) and is a Board Member of the Italian Association of Ophthalmologists (AIMO).
He has been a Faculty member of the European Vitreo Retinal Training School (Bremen), since its inception in 2001. This has resulted in contributing to the the training of over 1000 vitreo-retinal specialists.
Ever since his election to President of the European Vitreo Retinal Society (EVRS) he has also been actively involved in organising the Scientific Program of the Society’s Annual meeting (2017 Florence, 2018 Prague, 2019 Lisbon and the upcoming 2024 meeting in Budapest).
Particularly dear to him the invitation to deliver the Opening Lecture at the newly formed BEECS (British Emergency Eye Care Society) at Birmingham University in 2017 and the 2018 invitation to the annual meeting of the American Academy of Ophthalmology to lecture on the treatment of endophthalmitis.
He is a reviewer for multiple peer-reviewed scientific Journals.
He has contributed with a chapter in the book on Pediatric Vitreo Retinal Surgery (Springer Verlag) edited by Prof. Sengul Ozdek. He has also written several chapters and co-edited another book by Springer: Practical Manual of Vitreo Retinal Surgery.
Harminder Singh Dua, CBE, CMLJ, DL
MBBS, DO, DO(London), MS, MNAMS, FRCS(Edinburgh), FEBO, FRCOphth, FRCP(Edinburgh, Hon.), FCOptom.(Hon.), FRCOphth.(Hon.), FAICO (India, Hon.), MD, PhD, is Chair and Professor of Ophthalmology at the Queens Medical Centre, University of Nottingham since 1994, Consultant Ophthalmologist, Nottingham University Hospitals NHS Trust, Honorary Professor at Universita della Svizze, Lugano, since 2010 and Honorary Professor at the Research Institute of Ophthalmology, Cairo Egypt.
He was made Commander of the most excellent order of the British Empire by Her Majesty Queen Elizabeth II in her 2019 Birthday Honours list and served a full term as the High Sheriff of Nottinghamshire (2021-22). He was also awarded the NHS Parliamentary Lifetime Achievement award for the Midlands, commissioned as a Deputy Lieutenant (DL) in the Lieutenancy of Nottinghamshire and awarded the high rank of Commander of Merit of the Military and Hospitaller order of Saint Lazarus of Jerusalem (CMLJ). He is a member by invitation of two prestigious institutions namely the Academia Ophthalmologica Internationalis (AOI, an institution of 100 Professors of Ophthalmology) and the American Ophthalmological Society (AOS, the first UK member of this institution of 250 members).
He was the Master of the Oxford Ophthalmological Congress (2019-2020), President of several international organisations namely, Royal College of Ophthalmologists UK (2011-14), of EuCornea (2011-13), of the European association for vision and eye research (EVER, 2008), and of the EVER Foundation (2010-14 and 2016-2020). He was Editor in chief of the BJO (2007-14) and EuCornea Journal (2015-22) and has been recently appointed as Editor-in-chief of the Eye Journal to start from the first of January 2026, and as the International Convenor of the Cornea section of the World Ophthalmology Congress to be held in Prague in July 2026.
Among his over 150 awards and accolades are the Rotary Foundation Global Alumni Service to Humanity Award (2013), The Times Higher Education Award 2014 for ‘Research project of the year’ and the Melvin Jones Fellow (Award) Lions Clubs International Foundation for humanitarian work. He has been endowed with Honorary Fellowships of the Royal College of Ophthalmologists UK, the Royal College of Physicians of Edinburgh, the College of Optometrists UK, and the Collegium of the All India Ophthalmological Society; the highest accolades conferred by the respective Colleges. One eponymous lecture, “The Dua Lecture” Birmingham, and a seminar room in the Nottingham post-graduate centre, “The Dua Room” are named in his honour.
He has supervised 55 PhD/MPhil students, has over 500 publiations with over 33500 citations and an H-index of 87 (Google scholar July 2025). His discovery of the pre-Descemet’s layer (Dua’s layer) in 2013, in the human cornea has had considerable impact on lamellar corneal surgery and corneal pathology.
Dr. Kanellopoulos is an ophthalmic surgeon who specializes in the diagnosis and treatment of keratoconus, in refractive surgery with customization and the microsurgery of complicated cataract, as well as cornea transplantation in complicated glaucoma procedures.
His curriculum vitae comprises of:
Medical degree from the Un of S. Illinois, Ophthalmology Residency at the State University of New York at Brooklyn, Cornea and Refractive Clinical fellowship surgery at Cornell Un / North Shore University Hospital, Surgical. Glaucoma Clinical Fellowship as well as Keratoprosthesis training with Claes Dohlman, MD, PhD at the Harvard Medical School, Massachusetts Eye and Ear Infirmary.
1996 Assistant Professor of Ophthalmology and Director of Residency Training for the State University of New York at Brooklyn, 2001 Associate and in 2010-present Clinical Professor of Ophthalmology NYU Medical
School, New York City, NY.
He has presented over 1,000 original paper presentations at the major ophthalmology meetings: AAO, ASCRS, ESCRS and ARVO. He has published over 130 peer-reviewed papers, dozens of book chapters, as well as
hundreds of editorials in ophthalmology-related commercial journals.
His continued research interests focus in customization of laser treatments early diagnosis and management of keratoconus, biological factors involved in corneal wound healing.
Dr Mansouri is the Executive Vice President of the World Glaucoma Association.
He is also the Chief Medical Officer of iStar Medical, Belgium and Implandata GmbH, Germany. Dr Mansouri is the co-founder and President of the Swiss Glaucoma Research Foundation.
Dr Mansouri is a glaucoma specialist and a clinician-scientist. His academic accomplishments include over 180 peer-reviewed journal articles with an h-index of 63 (google scholar).
Since 2020, he has been continually ranked as one of the Top 20 Glaucoma Specialists in the world (Expertscape.com). He is on the editorial boards of the “Journal of Glaucoma” and the “Revista Brasileira de Oftalmologia”, is an associate editor of “Acta Ophthalmologica”, and is a contributing editor to the “International Glaucoma Review”. He is co-editor of the textbook “The Science of Glaucoma Management” and co-author of 12 textbook chapters.
In 2012, Dr Mansouri was the first ophthalmologist to give a TEDx talk, with the aim of improving glaucoma awareness.
Dr Mansouri’s clinical and scientific expertise has resulted in him being selected by the journal “The Ophthalmologist” as a Top 100 Ophthalmologist in the world (Power List 2024). Previously, he had been ranked twice in the top 40 under 40 power list by the journal “The Ophthalmologist”. He has also been chosen as a top ophthalmic innovator by the journal CRST Europe (Nov 2022). He has been featured on BBC World (“Secrets of the Superagers/Senses”).
He directs an active fellowship program which trains candidates from all continents and is a host to ICO fellows from developing countries.
Dr Mansouri has been the recipient of several international awards, including the prestigious Boberg-Ans from the Danish Ophthalmological Society, the MGS Alcon International Lecture, the American Academy of Ophthalmology (AAO) Achievement Award and AAO International Scholar Award, among others.
Dr. Kaweh Mansouri is a pioneer and expert in the use of intraocular pressure monitoring technology and a pioneer in MIGS. His research activities are focused on advancing 24-h IOP monitoring, as well as the development of new technologies in the field of glaucoma imaging and surgery.
With over two decades of experience in the pharmaceutical industry, Lasse is a seasoned executive known for driving strategic growth and operational excellence across international markets. He is currently serving as Vice President for the Central Region, EMEA at Santen, a Japan-based, global healthcare company focused exclusively on eye health. Lasse oversees operations spanning the Nordics, Baltics, DACH, UK & Ireland, and the Middle East—managing a regional team of approximately 200 international professionals.
In his role, he overlooks around 600 marketing authorizations for +30 prescription products across the EMEA region that help people protect and preserve their sight. He supports HR and finance operations for 17 representative offices and 3 filial entities across Central and Eastern Europe.
Lasse’s industry knowledge and cross-functional leadership have consistently contributed to the company’s growth and regional integration strategies. As a member of the Santen European Leadership Team, he plays a pivotal role in shaping Santen’s broader European business agenda, strengthening its position as a trusted leader in eye health. Lasse’s contribution has been crucial in ensuring seamless collaboration with key internal and external stakeholders.
Throughout his career, Lasse has demonstrated ability to lead diverse teams, navigate complex market environments, and deliver sustained commercial success in highly competitive landscapes.
Mr Leon Au is a Consultant Ophthalmic Surgeon specialising in glaucoma and cornea. He graduated from the University of Nottingham in 1998 with an ophthalmology prize of the year. He completed 8 years of general ophthalmology training in Nottingham and Manchester before undertaking separate subspecialty training fellowships in cornea, glaucoma and refractive surgery. He has been a dual-specialty consultant in the Manchester Royal Eye Hospital since February 2009. He is an international leader in the field of innovative glaucoma surgeries and is involved in many of the clinical trials
Dr. Livia Lumbroso-Le Rouic is an ophthalmologist specializing in ocular oncology. She serves as a senior physician at the Institut Curie in Paris, one of Europe’s leading cancer centers. Dr. Lumbroso-Le Rouic focuses primarily on the diagnosis and treatment of eye tumors, including uveal melanoma and retinoblastoma. Her work combines clinical care with research, aiming to improve therapeutic outcomes and preserve vision in patients with ocular cancers. She is also involved in academic teaching and has contributed to numerous scientific publications in her field.
Luís Abegão Pinto is the Head of the Glaucoma Clinic of the Department of Ophthalmology of Portugal’s largest Hospital (Hospital Santa Maria). He serves as Associate Professor of Ophthalmology at the Faculty of Medicine of Lisbon University, Portugal. His main areas of interest are Glaucoma Surgery, Artificial Intelligence and Screening.
He serves in the Executive Board of the European Glaucoma Society (EGS) since 2018 and he is currently the EGS Vice President. Moreover, he is co-chair of the EGS TaskForce on Glaucoma Surgery, co-editing the new “Guides on Innovations in Glaucoma Surgery”
He has authored or co-authored 105 indexed, peer-reviewed papers in Glaucoma. He is actively engaged in several scientific ophthalmological societies, including the EGS and EVER, having chaired or co-chaired a number of courses in international Ophthalmology societies’ meetings.
Professor (Dr.) Mahipal. S. Sachdev, Chairman & Medical Director of Centre for Sight is a renowned ophthalmic Surgeon who is recognized for his expertise in the area of Cataract, Refractive & Corneal Surgery, both nationally and internationally. He was honored with Padmashri award on January 26, 2007. In the year 2017, he attained Professorship in Ophthalmology & in year 2020 has been elected as President of All India Ophthalmological Society. He is widely credited to be pioneer in India in propagating the technique of Phacoemulsification for cataract surgery and Lasik Laser for removal of glasses.
In 1996, Professor (Dr.) Mahipal Sachdev stepped out of AIIMS with a dream of creating a world class eye hospital. “Centre for Sight” is an outcome of that.
Professor (Dr.) Mahipal is a visionary and leader. He has always been the torchbearer in the field of eye care pioneering several procedures including laser assisted blade less surgery for cataract and Lasik. Prof. Mahipal learned about “Phaco” (Stich less micro incision cataract surgery) while pursuing his fellowship in United States. He knew it was next big thing in ophthalmology. Prof. Mahipal was among the first to introduce Lasik and Phakic IOLs & Femtosecond laser technology for lasik. Prof. Mahipal also has pioneered blade free Femtocatarct technology in India.
He has authored over 5 books on cataract & Refractive surgery including the first book on phaco by an Indian Ophthalmologist. These books are today referred to by every budding Ophthalmologist. Prof. Mahipal is an active contributor of articles on eye health in mass media for the benefit of the general public also.
He has been recognized globally with fellowships and scholarships from the “Fifth International Symposium on Immunopathology”- Japan, “International Society of Eye Research”, “Research to Prevent Blindness”, New York, “Fisons award by the Contact Lens Association of Ophthalmologists”, USA amongst others. In India he has won the “A C Aggrawal Memorial Trophy”, “Col. Ranagachary Certificate”, “Krishna Sohan Singh Trophy”, “Dr Ishwar Chand Silver Jubilee Award” to name a few. Prof. Mahipal Sachdev has recently been awarded “Dr. S.N. Mitter Oration award” in DOS conference held in April 2017”. Prof. Mahipal has also received “Life Time Achievement Award- Ophthalmology” at Times Health Care Achievers program held in Delhi. To add on Prof. Mahipal was honored with a Gold Medal in KOSCON conference 2017 in Bengaluru.
Prof. Mahipal is an actively involved in Research & Development, he has been instrumental in the Development of the ELITA Femtosecond laser by J&J. He was the PI of the First-in-man clinical trials for the ELITA. He is also the first person in the world to perform the Flap as well as the Lenticule extraction procedure (SILK) on the ELITA platform.
Prof. (Dr.) Mahipal S. Sachdev was honored with Padamshree Prof. Dr. TP Lahane Award Award at MOSCON 2022. Further, he was honored with Dr. Hari Mohan Oration 2022 in 73rd DOS Conference at New Delhi. He is presently also member of the Global Advisory Board, J & J. Prof. Sachdev was felicitated with the APACRS Certified Educator (A.C.E) award, and was also awarded appreciation as the IIRSI representative, at the APACRS 2023, Singapore.
Prof. (Dr.) Mahipal S. Sachdev was awarded Hero of Ophthalmology award in KSOS 2023 at Thrissur, Kerala. Further, he was honored with Honorary Doctorate (D.Sc. Honoris Causa) at 19th Annual Convocation of the University held on 08 Dec 23 (Friday) at Amity University, Uttar Pradesh (AUUP), Noida.
Prof. (Dr.) Mahipal S. Sachdev has been conferred with the prestigious “AIOS – Dr. LP Agarwal Endowment Lecture 2024 and Achievement Award at AIOC 2024 held from 14 -18 Mar 24 at Kolkata, West Bengal and “ISCKRS Refractive Oration Award at ISCKRS Annual Conference held from 02 -04 Aug 2024 at New Delhi.
Prof. (Dr.) Mahipal S. Sachdev has been awarded with the prestigious “Asu Biswas Kanika Biswas Oration Award at Conference held on 11 Aug 2024 at Trenetralaya, Kolkata, West Bengal. Prof. (Dr.) Mahipal S. Sachdev has been awarded with the prestigious “Legend in Ophthalmology Award at Conference held from 03 -05 Jan 2025 at MM Joshi Eye Institute, Hubli, Karnataka. Prof. (Dr.) Mahipal S. Sachdev has been awarded with the prestigious “RP Centre Oration Award on 58TH RP Centre Foundation Day on 10 Mar 2025 at Delhi. Recentley, Prof. (Dr.) Mahipal S. Sachdev has been awarded with the prestigious “Senior Achievement Award at AIOS APAO Conference 2025 on 05 Apr 25 at Delhi.
Prof. (Dr.) Mahipal S. Sachdev is a rare combination of a brilliant surgeon, an entrepreneur and above all, a compassionate human being. He has ensured that the Indian Flag remains flying high in the domain of eye care and that the patients in India have access to the best and the latest when it comes to treating their eyes in line with his own mission statement “…. every eye deserves the best”.
Michael Assouline, MD, PhD, FEBO
Ophthalmic & Refractive Surgeon
Founder & Medical Director
Centre Ophtalmologique Iéna Vision 37 rue Galilée 75116 Paris, France www.ienavision.fr
Clinique de la Vision 131 rue de l’Université 75007 Paris, France
Mikajaki SA, Route de la Galaise 34 Plan-les-Ouates (Geneva) CH – 1228 Switzerland www.mikajaki.com
Michael Assouline, MD, PhD, FEBO, trained as a resident and a cornea fellow in Paris and in the USA. He held a number of positions in University Hospitals in Paris. In private practice since 1997, Dr Assouline founded the IénaVision Eye Center in Paris in 2010 (www.ienavision.fr). He also co-founded the Clinique de la Vision in Paris, still the leading Refractive Surgery Center in France (www.cliniquevision.fr). In 2018 he co-founded MIKAJAKI, a Geneva based company which developed the EyeLib ophthalmic Suite composed of a robotic ophthalmic diagnostic station (CE Mark obtained in september 2020, ISO certified June 2021), a conversational virtual agent diagnostic tool, and a full range multimodal AI powered Smart-Vision Report™. Over the last 30 years, Dr Assouline gave more than 400 lectures in 54 countries. He published 35 papers in peer-reviewed journals, 24 book chapters, and more than 150 professional articles.
Anterior segment surgeon, since 1994 – specialized in cataract, refractive and corneal transplant surgery
Posterior segment surgeon, since 2020
Eye Surgeon and co-manager in Oculus Eye Clinic – Bucharest
Affiliation:
Co-opted member of the ESCRS Board and of the ESCRS Educational Committee (2012 – 2016 – attending all the ESCRS Board meetings in 2012-2016
ESCRS Academy member – since January 2014, ongoing; invited speaker for several Academy meetings
ESASO Faculty member – since January 2014, ongoing; invited course presenter for ESASO
Surgical experience (1994 – present):
approx. 70000 cases of cataract surgery with PC-IOL implantatation (mostly phaco procedures; experience in astigmatism and presbyopia correcting lenses and in Femto-Assisted Cataract surgeries, since 2013
approx. 2000 cases of corneal transplantation and combined procedures
approx. 500 vitreo-retinal surgeries
experience in office-Laser procedures (YAG capsulotomies, iridotomies, ALT/SLT)
Speaker for several congresses and meetings in national and international congresses (including several editions of ASCRS, ESCRS 2006-2025, SICSSO 2017-2021, Videocatarattarefrattiva, 2010 – 2025), AICCER 2021 and 2024, Koln Advent Symposium 2022, EuCornea 2022 – 2023, GIVRE 2023, MEACO- AAO session 2023, ESOIRS 2024.
Experience in national and international Live surgery sessions, as surgeon: several times in ESCRS meetings, in MTK congresses, HSIIRS meetings, ESASO meetings and others, between 2006 and 2019
Experience in International clinical studies, GCP certified, since September 1999 to present
Books:
“Cataract surgery complications” – Lucio Buratto, Stephen Brint – SLACK Incorporated, 2013 – Chapter: Complications of Phacoemulsification and „Practical guide for avoiding and treating complications in cataract surgery” – Curtea veche Publisher, 2019
Dr Ramesh Kekunnaya is the Network Director – Technology Innovation at LVPEI. The other major portfolios that he is handling include Director of the Child Sight Institute, Director of Centre for Technology Innovation, and Head – Jasti V Ramanamma Children’s Eye Care Centre at LVPEI. Dr Kekunnaya is also an Executive Bureau Director of the World Society for Paediatric Ophthalmology and Strabismus (WSPOS), Founder Executive Bureau member of Paediatric Ophthalmology and Strabismus Network (POSN) of India, and an Administrative Council Member of the International Strabismological Association (ISA).
Dr Kekunnaya received his basic medical training from the Karnataka Medical College, Hubli, and specialized in ophthalmology from the Government Medical College, Mysore. He completed a fellowship in Paediatric and Neuro Ophthalmology, Strabismus and Comprehensive Ophthalmology at LVPEI, followed by a Paediatric Ophthalmology and Strabismus Fellowship (AAPOS accredited) at the Jules Stein Eye Institute, University of California, USA. His core clinical interests include simple and complex strabismus in adults and children (squint), childhood cataract, vision development, myopia, amblyopia (lazy eye) and neuro-ophthalmological disorders in children.
He has been honoured with Achievement Awards from the American Academy of Ophthalmology (AAO) and Asia Pacific Academy of Ophthalmology. Dr Kekunnaya is also the recipient of the International Scholar Award and International Education Award from AAO, and Honor Award from the American Association for Pediatric Ophthalmology and Strabismus.
Dr Kekunnaya has authored over 150 publications in peer-reviewed journals in addition to having written over 25 text book chapters. He is the Paediatric Ophthalmology and Strabismus Section Editor for the British Journal of Ophthalmology, the Current Eye Research, and the BMJ Open Ophthalmology. He has presented widely, is invited as keynote speakers at both national and global levels, and is passionate about teaching.
Rania Maklad is the CEO and Co-Founder of OCUWELL, a health technology company focused on improving eye care through innovation and accessibility. With a background in healthcare management and digital innovation, Rania has played a key role in shaping OCUWELL’s goal of making vision screening and eye health monitoring more proactive and personalized.
Under her leadership, OCUWELL has grown from a simple idea into a developing startup, known for its AI-powered diagnostics and eye health solutions. Rania’s vision has helped position OCUWELL as an emerging player in the region’s health-tech sector, collaborating with clinics, research institutions, and corporate wellness programs.
Rania is also passionate about promoting inclusive innovation and supporting women’s involvement in technology, encouraging others in the Middle East to explore how digital solutions can enhance quality of life.
Consultant Cornea and Refractive surgery Clinical and translational Scientist, Narayana Nethralaya, Bangalore, INDIA GROW laboratories Faculty, Dept. of Ophthalmology, Univ. Maastricht.
Prof. Dr. Rohit Shetty is the Vice Chairman of Narayana Nethralaya Eye Institute. He is a Professor at Sri Devaraj Urs Medical College, India and an Adjunct Associate Professor at MS Ramaiah Medical College, Bangalore and is an Affiliate Associate Professor and PhD guide at the Maastricht University in the Netherlands. Prof. Dr. Rohit Shetty has over 200 Publication in peer reviewed indexed Journals. He is a Corneal Refractive Surgeon at Narayana Nethralaya Eye Institute, Bangalore, India. His other areas of work include Neuro-ophthalmology electrophysiology.
Prof. Dr. Rohit Shetty defended his PhD from Maastricht University, Netherlandson Understanding the Clinical, Immunological and Genetic Molecular Mechanism of Keratoconus. He has a special interest in the management of Keratoconus, tear film abnormalities and biomarkers. He has introduced cutting edge technology at Narayana Nethralaya and spearheads treatment for challenging eye disorders.
In the 2015 annual conference of the All India Ophthalmological Society, Dr. Rohit Shetty won the prestigious Col. Rangachari award for the overall best paper of the conference for his work on “Is Inflammation Driving Keratoconus? – A Holistic Study Of Molecular Pathways”.
The American Academy of Ophthalmology recently conferred an achievement award to Dr. Rohit Shetty for the distinguished services he has rendered over the years to the programs of the society.
Dr. Rolando Toyos is a globally renowned ophthalmologist and one of the world’s leading dry eye specialists, celebrated for his groundbreaking contributions to the treatment of dry eye disease (DED). As the founder and medical director of Toyos Clinic, with locations in Tennessee, Mississippi, and New York City, Dr. Toyos has transformed the landscape of ocular health through his innovative approaches and dedication to patient care.
A pioneer in the field, Dr. Toyos is the inventor of Intense Pulsed Light (IPL) therapy for dry eye, a revolutionary treatment that targets meibomian gland dysfunction (MGD), a primary cause of evaporative dry eye. His FDA-approved Toyos Protocol, developed over 25 years of research, is the only peer-reviewed IPL protocol for DED and is utilized by top eye care centers worldwide, including prestigious institutions like the Mayo Clinic, Johns Hopkins, and Stanford. Dr. Toyos has trained hundreds of surgeons globally, establishing himself as a trailblazer in advancing dry eye treatment standards.
In addition to IPL, Dr. Toyos has developed cutting-edge technologies like The Q, a portable light therapy device that empowers patients to manage dry eye symptoms at home and Platelet Rich Plasma PRP eyedrops and microneedling of the tear producing glands. His holistic approach to DED emphasizes the critical role of diet and lifestyle, detailed in his acclaimed book, *Toyos Dry Eye Diet: What to Eat to Heal Your Dry Eyes*, which provides science-based guidance for lasting relief. His earlier works, including *Dry Eye Disease Treatment in the Year 2020*, are celebrated by patients and professionals alike for their insights into innovative treatments.
Board-certified in ophthalmology, Dr. Toyos is also a highly experienced surgeon, having performed over 35,000 cataract surgeries, 25,000 LASIK procedures, and 20,000 glaucoma laser treatments. His expertise extends to serving at one time as the official eye doctor for professional sports teams, including the Memphis Grizzlies and Memphis Redbirds, and as the former president of the Sports Ophthalmology Society of America.
Recognized as a Castle Connolly Top Doctor and Newsweek America’s Best Doctors, Dr. Toyos has received numerous accolades, including the Humanitarian Award from the Jazz Foundation of America for his work with Hurricane Katrina victims and the Leadership Award from the National Hispanic Professional Organization. His commitment to community service includes mission trips to Nicaragua, Honduras, Colombia, and Haiti, as well as volunteering with Eye Care America to provide free care to underserved populations.
Dr. Toyos earned his Bachelor’s and Master’s degrees from the University of California, Berkeley, and Stanford University, respectively, and his medical degree from the University of Illinois College of Medicine, where he graduated with James Scholar Academic Honors and was Class President. He completed his ophthalmology residency at Northwestern University and Chicago Children’s Hospital.
Through his innovative treatments, extensive research, and compassionate care, Dr. Rolando Toyos continues to redefine the standard of care for dry eye disease, offering hope and relief to patients worldwide.
Professor of Ophthalmology at Universidad Complutense de Madrid (Spain) and Chief of Motility Unit and Pediatric Opthalmology at Hospital Universitario Clinico San Carlos of Madrid.
Honorary Doctorates Fellowships:
Stefano Barabino is Head of the Ocular Surface & Dry Eye Center at the Sacco Hospital, Milan University, Italy. He received his medical doctor degree from Genoa University, completed his residency in Ophthalmology, and received his Ph.D. degree in Immunology.
Dr. Barabino completed a two-year fellowship at Harvard University, in Boston, USA. As specialist in dry eye, ocular surface diseases, and contactology, he has published more than 200 scientific articles in Italian and International scientific journals. He is an active member of several European and International professional societies, President of the Italian Society of Ocular Surface, board member of Ocular Immunology & Inflammation, Eye & Contact Lens, The Ocular Surface, BMC Ophthalmology, Current Eye Research, TVST.
Dr. Barabino has been an active member of the Tear Film & Ocular Surface Society (TFOS) since its inception in 2000 and founding member of the European Dry Eye Society (EUDES).
Tamer Mahmoud, MD, PhD is a professor of Ophthalmology at Oakland University William Beaumont School of Medicine and the director of the vitreoretinal fellowship at Associated Retinal Consultants. He moved from North Carolina in 2017 where he was the program director of the vitreoretinal surgery fellowship at the Duke University Eye center and a tenured associate professor at Duke. He has developed many surgical techniques over the years with his fellows including the use of subretinal air to displace submacular hemorrhage in 2013 and developed and performed the first human autologous retinal transplantation in 2015. He also introduced chandelier buckles to the United States and in 2017, developed the ILM retracting door technique for macular holes. The nano subretinal gateway device was developed in 2019 to access the subretinal space without PPV to displace subretinal hemorrhage, but also for injection of gene therapy, drugs, removal of PFO and tumor biopsy. In 2022, the concept of using the epiretinal membrane to close large macular holes was introduced in cases of combined large holes with membranes. In 2023, he developed and performed the first combined amniotic and autologous retinal transplant for large refractory myopic macular holes with some atrophy. For the last few years, Dr. Mahmoud has focused on running global studies to treat macular holes by working with surgeons around the world to develop guidelines to treat challenging holes using many techniques that have been developed over the years.
Dr. Mahmoud graduated Valedictorian from Ainshams University, finished his internship, residency and vitreoretinal fellowship at the Duke University Eye Center. He is a member of the American Academy of Ophthalmology (AAO), the Association of Research in Vision and Ophthalmology (ARVO), the American Society of Retina Specialists, the Club Jules Gonin, the Macula Society, the Retina Society, The Vitbuckle society, and the United States Masters Swimming Association. He is a reviewer for many Ophthalmology journals and a principal investigator on many clinical trials sponsored by the industry and the National Eye Institute. He has been invited as a guest speaker all over the world. Dr. Mahmoud is certified by the American Board of Ophthalmology and is licensed in the states of California, Michigan, and North Carolina.
Dr. Mahmoud received the Edward K. Isbey, Jr., M.D. Resident Award for “Excellence in Clinical Care, Ethics, and Research” from the Duke Eye Center, the Retina Research Foundation/”Joseph M. and Eula C. Lawrence” award from ARVO, the “Senior Honor Award” and the “Presidential Honor Award” from the American Society of Retina Specialists, the “Achievement Award” from the AAO, the prestigious Robert A. Machemer research award from the Duke Eye Center, the “Distinguished Teacher of the Year Award” from the Kresge Eye Institute and the “Golden Globe Award” for residents’ education from the Duke Eye Center.
Dr. Mahmoud has been on the list of Best Doctors in America since 2009 and Castle Connolly Top Doctors in Ophthalmology. He was the director of the Vitreoretinal Surgery Fellowship at the Kresge Eye Institute in Michigan before moving back to Duke in 2011 to join the retina faculty. Wayne State University-Kresge Eye Institute established the “Tamer H. Mahmoud, MD endowed fellowship research award” in 2012. This award is bestowed yearly to the fellow presenting the best paper.
Dr. Mahmoud is a founder of the Duke Surgical Rounds Courses launched at national and international conferences in 2013, and co-founder of the Duke fellows advanced vitreous surgery course (fAVS). He served on the national Therapeutic Safety Committee (TSC) for monitoring of drugs and devices and founded the North Carolina Retina Club (NCRC) in 2012 to allow interaction and collaboration between retina specialists in the state of North Carolina.
A natural visionary Leader with unique Coaching and Transformational abilities with a phenomenal track record of challenging businesses turnaround.
Having been in Pharma for more than 35 years, heading a mix of senior Commercial and General Management Leading roles over the last 26 years, the last 15 years, in particular, were strong career highlights.
Between 2009 and 2018, filled the senior Executive Roles as a Regional President leading Pfizer’s various business segments, Consumer Health, Nutrition, and Pharmaceuticals, and leading businesses ranging from $400M – $B 1.3 in regions like Europe, the Middle East, and Africa.
Currently the CEO of Jamjoom Pharma, one of the leading regional players in the Middle East.
Founder, CataractCoach.com
The world’s largest cataract surgery teaching website with 1850+ videos, 16 million views, 52000 subscribers, and a new video every day.
Academic Appointment:
Honors:
Moreover, Dr. Uday Devgan is the winner of the Ibn A Haytham Medal Award in the 10th EPOMEC 2023.
Executive Vice President of Research & Development and Chief Medical Officer
Yehia Hashad is an ophthalmologist and retinal specialist with more than 25 years of leadership experience in various ophthalmology global research and development roles, including his current role as the Executive Vice President of Research & Development and Chief Medical Officer at Bausch + Lomb.
Most recently, Dr. Hashad was with Allergan/AbbVie where he served as Senior Vice President and Head of R&D for Allergan Aesthetics from 2020 through August 2021. There, he oversaw the development of more than 40 programs that spanned pharmaceutical products, fillers, reconstructive surgery, devices and consumer skin care. From 2010 until Allergan’s acquisition by AbbVie in 2020, Dr. Hashad held a number of executive R&D positions at Allergan, including Senior Vice President and Head of Global Clinical Development; Vice President and Global Head of Clinical Development, Ophthalmology, Dermatology and Medical Aesthetics; and Vice President and Global Head of the Ophthalmology and Retina therapeutic areas.
Prior to Allergan, Dr. Hashad spent five years with Novartis Pharma AG, where he served as a Global Medical Director for age-related macular degeneration-related treatments Visudyne® and Lucentis® and as a Medical Director, Ophthalmology, for the European region. From 1996 to 2005, he held positions of increasing responsibility at T3A Pharma Group.
Dr. Hashad obtained his Master of Science in Medical and Surgical Ophthalmology from Cairo University and a business degree from INSEAD in France. He previously served on the boards of The Glaucoma Research Foundation and the National Alliance of Eye and Vision Research and is currently a board adviser for the University of California Irvine Research Center.
Since 2018, he has been the Deputy Director for Innovation at the Federal State Budgetary Scientific Institution “Research Institute of Eye Diseases”.
He is the director of the Federal State Budgetary Institution “Scientific Research Institute of Eye Diseases” from 2020 to the present.
In 2022, Dr. Yusef was awarded the academic title of professor.
In 2022, he was awarded the state award of the Russian Federation – the Medal of Friendship.
Yusef Naim Yusef carries out close scientific cooperation with many leading ophthalmologists and the clinics of the world, he is a certified specialist of the world’s leading manufacturers of ophthalmic equipment: Alcon, Baush&Lomb, Schwind, Topcon, etc.
Yusef Naim Yusef is one of the most respected ophthalmologists in Russia.
Dr. Youssef plays a big role in improving Russian-Arab relations. Thousands of patients have been consulted and received surgical care from the Arab world. The doctor has repeatedly performed microsurgical eye operations in the Arab world. Special attention is paid to Russian-Syrian relations.
Dr. Yusef has repeatedly performed on central Russian television channels, several cycles of broadcasts on Al Jazeera and Russia Aliom channels were dedicated to him, and he owns many publications in the central press.
Dr. Oshima graduated from Osaka University Medical School and completed his residency and fellowship in vitreoretinal surgery at Osaka University Hospital under the mentorship of the late Dr. Yasuo Tano. After serving for over a decade as an Associate Professor at Osaka University, he is now the Founder and Director of the Seiyukai Medical Corporation, which operates three specialized centers for vitreoretinal and cataract surgery in Osaka, Japan. Collectively, these centers perform more than 5,000 surgical cases annually.
Dr. Oshima is internationally recognized for his pioneering work in developing the 27-gauge vitrectomy system, which has significantly advanced minimally invasive retinal surgery. He is a prolific author of scientific papers published in leading journals such as Ophthalmology, American Journal of Ophthalmology (AJO), and British Journal of Ophthalmology (BJO).
A sought-after speaker, Dr. Oshima has delivered numerous invited lectures across Asia, Europe, and the United States, and has performed live surgical demonstrations at major international meetings including the Frankfurt Retina Meeting, Floretina, and the Cairo Retina Meeting.
He serves on the Editorial Board of Retina Today and holds memberships in several prestigious ophthalmologic societies, including the American Academy of Ophthalmology (AAO), the American Society of Cataract and Refractive Surgery (ASCRS), and currently serves as the Liaison for International Affairs for the American Society of Retina Specialists (ASRS).
In recognition of his contributions to the field, Dr. Oshima has received numerous honors, including:
Sign up now to our newsletter
